Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Venker Eric | President & COO | Feb 09 '24 | Option Exercise | 3.85 | 96,950 | 373,258 | 629,157 | Feb 09 09:00 PM | Venker Eric | President & COO | Feb 09 '24 | Sale | 10.92 | 96,950 | 1,058,694 | 532,207 | Feb 09 09:00 PM | Ramaswamy Vivek | 10% Owner | Jan 02 '24 | Sale | 11.05 | 3,000,000 | 33,150,000 | 51,929,426 | Jan 03 04:56 PM | Venker Eric | Chief Operating Officer | Oct 05 '23 | Sale | 10.11 | 153,027 | 1,547,103 | 595,397 | Oct 04 09:30 PM | Venker Eric | Chief Operating Officer | Oct 04 '23 | Option Exercise | 3.85 | 153,027 | 589,154 | 748,424 | Oct 04 09:30 PM | Venker Eric | Chief Operating Officer | Oct 03 '23 | Option Exercise | 3.85 | 606,221 | 2,333,951 | 1,201,618 | Oct 04 09:30 PM | Venker Eric | Chief Operating Officer | Oct 03 '23 | Sale | 10.25 | 606,221 | 6,213,765 | 595,397 | Oct 04 09:30 PM | Venker Eric | Chief Operating Officer | Oct 02 '23 | Option Exercise | 3.85 | 440,752 | 1,696,895 | 1,036,149 | Oct 04 09:30 PM | Roivant Sciences Ltd. | Director | Oct 02 '23 | Buy | 38.00 | 1,526,316 | 58,000,008 | 79,805,331 | Oct 04 05:15 PM | Venker Eric | Chief Operating Officer | Oct 02 '23 | Sale | 10.80 | 440,752 | 4,760,122 | 595,397 | Oct 04 09:30 PM | SVF Investments (UK) Ltd | 10% Owner | Sep 28 '23 | Sale | 12.60 | 10,000,000 | 126,000,000 | 73,031,667 | Oct 02 09:00 PM | Gold Daniel Allen | Director | Sep 28 '23 | Sale | 11.55 | 10,000,000 | 115,500,000 | 100,804 | Oct 02 08:55 PM | QVT Financial LP | Director by Deputization | Sep 28 '23 | Sale | 11.55 | 10,000,000 | 115,500,000 | 100,804 | Oct 02 08:43 PM | MANCHESTER KEITH S | Director | Sep 28 '23 | Sale | 11.55 | 6,896,144 | 79,650,463 | 5,023,787 | Oct 02 09:05 PM | Venker Eric | President & COO | Sep 27 '23 | Option Exercise | 3.85 | 500,000 | 1,925,000 | 1,095,397 | Sep 29 09:30 PM | Venker Eric | President & COO | Sep 27 '23 | Sale | 13.02 | 500,000 | 6,510,000 | 595,397 | Sep 29 09:30 PM | Kumar Rakhi | Chief Accounting Officer | Sep 08 '23 | Option Exercise | 6.48 | 99,350 | 643,788 | 297,300 | Sep 12 09:30 PM | Venker Eric | Chief Operating Officer | Sep 08 '23 | Option Exercise | 3.85 | 106,430 | 409,756 | 718,243 | Sep 12 09:32 PM | Venker Eric | Chief Operating Officer | Sep 08 '23 | Sale | 12.19 | 106,430 | 1,297,382 | 611,813 | Sep 12 09:32 PM | Kumar Rakhi | Chief Accounting Officer | Sep 08 '23 | Sale | 12.18 | 99,350 | 1,210,083 | 197,950 | Sep 12 09:30 PM | Venker Eric | Chief Operating Officer | Sep 06 '23 | Option Exercise | 3.85 | 5,926 | 22,815 | 617,739 | Sep 06 09:30 PM | Venker Eric | Chief Operating Officer | Sep 06 '23 | Sale | 11.85 | 5,926 | 70,223 | 611,813 | Sep 06 09:30 PM | Venker Eric | Chief Operating Officer | Sep 05 '23 | Option Exercise | 3.85 | 73,275 | 282,109 | 685,088 | Sep 06 09:30 PM | Kumar Rakhi | Chief Accounting Officer | Sep 05 '23 | Option Exercise | 6.48 | 1,724 | 11,172 | 199,674 | Sep 07 09:30 PM | Venker Eric | Chief Operating Officer | Sep 05 '23 | Sale | 11.92 | 73,275 | 873,438 | 611,813 | Sep 06 09:30 PM | Kumar Rakhi | Chief Accounting Officer | Sep 05 '23 | Sale | 12.00 | 1,724 | 20,688 | 197,950 | Sep 07 09:30 PM | Venker Eric | Chief Operating Officer | Sep 01 '23 | Option Exercise | 3.85 | 14,763 | 56,838 | 626,576 | Sep 06 09:30 PM | Venker Eric | Chief Operating Officer | Sep 01 '23 | Sale | 11.90 | 14,763 | 175,680 | 611,813 | Sep 06 09:30 PM | Venker Eric | Chief Operating Officer | Aug 14 '23 | Option Exercise | 3.85 | 59,811 | 230,272 | 687,729 | Aug 16 09:34 PM | Venker Eric | Chief Operating Officer | Aug 14 '23 | Sale | 11.89 | 59,811 | 711,153 | 627,918 | Aug 16 09:34 PM | Venker Eric | Chief Operating Officer | Aug 03 '23 | Option Exercise | 3.85 | 44,629 | 171,822 | 672,547 | Aug 07 09:30 PM | Kumar Rakhi | Chief Accounting Officer | Aug 03 '23 | Option Exercise | 6.48 | 3,681 | 23,853 | 203,009 | Aug 03 09:30 PM | Venker Eric | Chief Operating Officer | Aug 03 '23 | Sale | 11.93 | 44,629 | 532,424 | 627,918 | Aug 07 09:30 PM | Kumar Rakhi | Chief Accounting Officer | Aug 03 '23 | Sale | 12.00 | 3,681 | 44,172 | 199,328 | Aug 03 09:30 PM | Venker Eric | Chief Operating Officer | Aug 02 '23 | Option Exercise | 3.85 | 16,397 | 63,128 | 644,315 | Aug 02 09:30 PM | Venker Eric | Chief Operating Officer | Aug 02 '23 | Sale | 11.86 | 16,397 | 194,468 | 627,918 | Aug 02 09:30 PM | Venker Eric | Chief Operating Officer | Aug 01 '23 | Option Exercise | 3.85 | 61,397 | 236,378 | 689,315 | Aug 02 09:30 PM | Kumar Rakhi | Chief Accounting Officer | Aug 01 '23 | Option Exercise | 6.48 | 336 | 2,177 | 199,664 | Aug 03 09:30 PM | Venker Eric | Chief Operating Officer | Aug 01 '23 | Sale | 11.92 | 61,397 | 731,852 | 627,918 | Aug 02 09:30 PM | Kumar Rakhi | Chief Accounting Officer | Aug 01 '23 | Sale | 12.00 | 336 | 4,032 | 199,328 | Aug 03 09:30 PM | Venker Eric | Chief Operating Officer | Jul 31 '23 | Option Exercise | 3.85 | 117,372 | 451,882 | 745,290 | Aug 02 09:30 PM | Venker Eric | Chief Operating Officer | Jul 31 '23 | Sale | 11.91 | 117,372 | 1,397,901 | 627,918 | Aug 02 09:30 PM | Venker Eric | Chief Operating Officer | Jul 27 '23 | Option Exercise | 3.85 | 23,622 | 90,945 | 651,540 | Jul 27 09:30 PM | Venker Eric | Chief Operating Officer | Jul 27 '23 | Sale | 10.98 | 23,622 | 259,370 | 627,918 | Jul 27 09:30 PM |
|